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Abstract
Background: The relationship between measures of visual function and gait related risk factors for falls is unclear. In this study, we examine 
the relationship between visual function (visual acuity [VA] and contrast sensitivity [CS] at multiple spatial frequencies) and quantitative 
spatiotemporal gait, using a large, nationally representative sample of community dwelling older adults.
Methods: Participants aged 50 and over were recruited as part of The Irish Longitudinal Study on Ageing (TILDA). VA was measured with the 
LogMAR chart according to the Early Treatment of Diabetic Retinopathy Study protocol. CS was measured at five spatial frequencies ranging 
1.5 to 18 cycles per degree (cpd) using the Functional Acuity Contrast Test. Gait speed, cadence, and stride length were measured using the 
GAITRite system. Multivariate analysis examined associations between gait and visual performance parameters adjusting for socioeconomic, 
physical, cognitive, and mental health covariates.
Results: Data from 4,678 participants were analyzed (age 61.7 ± 8.3 years, 54.1% woman). Poorer CS at 1.5 cpd and 3.0 cpd (low spatial 
frequency) was independently associated with decreased stride length (CS at 1.5 cpd: β = .031; p = .001 and CS at 3.0 cpd: β = .020; p = .001) 
but not cadence or gait speed. There was no evidence of an association between VA and any of the gait variables considered (p > .05).
Conclusion: Reduced CS, at low spatial frequencies, is independently associated with shorter stride length, while VA is not associated with any 
gait measures. This evidence suggests that it may be necessary to consider refocus of the assessment of vision to include the most appropriate 
measures.
Keywords: Contrast sensitivity—Visual acuity—Falls
Thirty percent of older adults fall each year (1,2). The consequences 
of falls are many and include injury, increased rates of hospitaliza-
tion, fear of falling, mortality, and early admission to long-term care 
(3). Falls are associated with a significant economic burden with the 
annual cost of falls in the United States estimated to be $19.2 bil-
lion (4). Elucidating mechanisms and identifying novel biomarkers 
of falls risk is thus paramount in older adults.
Gait impairments are one of the primary risk factors for falls in 
older adults with decreased gait speed and increased gait variabil-
ity amongst a wide range of important features (2). Deterioration 
in visual performance is an accepted consequence of senescence (5), 
and is associated with increased falls rates (6,7). There are a broad 
range of measures of visual performance including visual acuity (VA) 
and contrast sensitivity (CS). Optimization of VA has been identi-
fied as an important intervention in the American Geriatrics Society 
and British Geriatrics Society guidelines for the prevention of falls 
in the community (8). However, the relationship between measures 
of visual function and gait related risk factors for falls is less clear.
Although it is generally accepted in practice that vision influ-
ences gait patterns, the results from the small number of research 
studies addressing this question are conflicting. Some studies report 
no independent association between VA and common gait meas-
ures, that is, gait speed, cadence, and stride length (9–12). However, 
one large study (n  =  5,143) of older adults (age >70  years) notes 
that severe impairment in VA, after adjusting for age and gender, 
is associated with an inability to complete an 8-foot walk test (13). 
Another (n = 782) indicates, after adjusting for age, gender, previous 
stroke and diabetes, a significant association between failure on the 
Buck Center Walking Test (14) and reduced VA. Both these studies 
however, use gait measures which contain additional components of 
kinematic performance, for example, turning or physical endurance. 
Poorer CS, as measured using the Pelli-Robson test, has been inde-
pendently associated with slower gait speed, shorter stride length, 
wider step width, increased double support time (10) and failure on 
the Buck Center Walking Test (14).
These studies have a number of limitations. Firstly, a broad range 
of gait, mobility and CS assessment methodologies and measures 
have been used, making comparison across studies difficult (9–15). In 
most cases, CS was measured at one spatial frequency with the Pelli-
Robson (9,12,14) or Melbourne Edge Test (10,11,15), thereby pre-
venting full characterization of the relationship between CS and gait 
parameters and its dependence on spatial frequency. Furthermore, 
previous models adjusted for a narrow range of potential confound-
ers (9–15), with two studies focusing on selected populations, that 
is, age-related macular degeneration (10) and older women (11) and 
are therefore less generalizable to a broader population.
In this study, we examine the relationship between visual func-
tion (VA and CS at multiple spatial frequencies) and quantitative 
spatiotemporal gait parameters using a large, nationally representa-
tive sample of well-characterized, cognitively intact community 
dwelling older adults.
Methods
Participants
The Irish Longitudinal Study on Ageing (TILDA) is a large, nation-
ally representative study of community dwelling adults aged 50 years 
and over, resident in Ireland. A stratified, clustered sample of 8,175 
individuals was recruited using the RANSAM sampling frame-
work (16), the details of which have been outlined previously (17). 
Ethical approval was provided by the Faculty of Health Sciences 
Research Ethics Committee at Trinity College Dublin. All partici-
pants provided written informed consent and the study adhered to 
the Declaration of Helsinki. The data presented here are based on 
wave 1 of the study which was undertaken between October 2009 
and July 2011.
Social interviewers visited participants in their own homes 
where they completed a computer-assisted personal interview which 
addressed questions on socioeconomic, physical, cognitive and men-
tal health factors. Participants were also invited to attend a dedicated 
health centre for a research nurse led health assessment (18).
Inclusion criteria included participation in the health centre 
assessment, completion of gait and vision assessments, a Mini-
Mental State Examination score ≥18 and no history of Parkinson’s 
disease.
Assessment of Vision
VA was measured according to the Early Treatment of Diabetic 
Retinopathy Study (ETDRS) protocol using a LogMAR chart (19).
Test results for the better eye were expressed in logarithmic units 
ranging from 1 (20/200) to −0.3 (20/10), with lower values indica-
tive of better vision.
CS was measured under mesopic conditions using the Functional 
Acuity Contrast Test (F.A.C.T.) incorporated in the Functional 
Vision Analyzer (Stereo Optical Co., Inc., Chicago, IL). The 
Functional Vision Analyzer is internally illuminated and as such is 
not influenced by varying light levels in examination rooms. The 
F.A.C.T. developed by Ginsberg (20) uses sinusoidal wave gratings 
to test CS at five different spatial frequencies: 1.5, 3, 6, 12, and 18 
cycles per degree (cpd), corresponding to low (1 and 3 cpd), mid (6 
cpd), and high (12 and 18 cpd) spatial frequencies. CS was measured 
monocularly for the eye with better VA resulting in a CS score (rang-
ing 0–9) at each spatial frequency.
Assessment of Gait
Gait assessment was performed using a 4.9 m GAITRite electronic 
walkway (CIR Systems Inc., Sparta, NJ) which automatically records 
participant footfalls and calculates spatiotemporal gait parameters. 
Participants were asked to walk at a normal pace, starting 2.5 m 
before and stopping 2.0 m after the walkway to control for accelera-
tion and deceleration effects. Each participant completed two walks 
and the data from both were combined.
Three gait variables were analyzed: gait speed, cadence, and stride 
length. Gait speed (cm/s) is the average speed over the two walks. 
Cadence is the average number of footfalls per minute. Stride length 
(cm) is the distance between sequential initial contacts with the ground 
for the same limb. The average stride length of the right and left lower 
limbs was used in this study. These three variables are related accord-
ing to the equation: Gait speed = stride length × cadence/ 120.
Covariates
During the computer-assisted personal interview, participants 
reported their level of educational attainment, a doctor’s diagnosis 
of the following chronic conditions: heart attack or heart failure or 
angina, hypertension, high cholesterol, stroke, diabetes, lung dis-
ease, asthma, arthritis, osteoporosis, cancer, peptic ulcer disease, and 
hip fracture. This was categorized as 0, 1, 2, and 3 or more chronic 
conditions. The participants’ regular medications were recorded 
and coded according to the Anatomical Therapeutic Chemical 
(ATC) Classification codes. Depressive symptoms during the past 
week were assessed using the eight-item Centre for Epidemiological 
Studies Depression scale (CES-D) (21). Participants were also asked 
whether they had fallen in the past year and if so, on how many 
occasions. The responses were categorized into 1, 2, and 3 or more 
falls. Participants also indicated if they felt unsteady when they stood 
or walked, whether they had ever been diagnosed with cataracts, 
glaucoma or age-related macular degeneration and whether they had 
undergone cataract surgery in the past.
Height (cm) and weight (kg) were measured using a SECA height 
rod and weighing scales respectively. Global cognition was assessed 
using the Mini-Mental State Examination (22). Executive function 
was assessed using the difference in time taken to complete trail 1 
and trail 2 tasks in the color trails test (23). Processing speed was 
assessed using a choice reaction time (CRT) test. In this test, par-
ticipants held a button down, released it in response to an on-screen 
stimulus and pressed the appropriate target button. The mean time 
from 100 appearances of the stimulus to pressing the correct but-
ton is the total response time. Maximum grip strength (kg) was 
measured as the highest score from two tests on each hand using 
a Baseline hydraulic hand dynamometer (Fabrication Enterprises, 
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White Plains, NY). Participants wore distance corrective lenses if 
required during vision and gait testing.
Statistical Analysis
Demographics of those included in the study were examined using 
Chi-squared test statistics and independent t tests.
Pearson’s and Spearman’s rank correlations were used to 
examine the univariate relationships between VA, CS, and the gait 
variables (speed, cadence, and stride length). Multivariate linear 
regression models were constructed to investigate the associations 
between VA, CS and the three dependent gait variables (speed, 
cadence, and stride length). For each dependent variable, two 
models were created. Model 1 adjusted for age, gender, education, 
height, and weight. Model 2 also adjusted for history of falls, num-
ber of medications, number of chronic conditions, depressive symp-
toms, color trail time difference, Mini-Mental State Examination, 
total response time, grip strength, history of cataracts (treated and 
untreated), history of glaucoma, and age-related macular degen-
eration. All data were analyzed using Stata Version 12 (StataCorp, 
College Station, TX). All regressions were adjusted to account for 
the clustered sampling design and a False Discovery Rate procedure 
applied to correct p values for multiple testing. Sensitivity analyses 
were also performed to examine the effects of controlling for age2, 
age–gender interactions and averaging CS values across 1.5–18 cpd 
on the regression results.
Results
Characteristics of the Study Sample
Of the 5,028 participants (aged ≥ 50 years) who attended the TILDA 
health assessment, 4,678 were included in the study. Reasons for 
exclusion were a history of Parkinson’s disease (n = 16), non-com-
pletion of gait assessment (n = 75), non-completion of VA assessment 
(n  =  20), non-completion of the CS test (n  =  228), and moderate 
to severe cognitive impairment, defined as an Mini-Mental State 
Examination score less than 18 (n = 11). The mean age of the sample 
was 61.7 ± 8.3 years, 54.1% of whom were woman. The character-
istics of the sample are outlined in Table 1.
Univariate Analysis of Vision and Gait
VA was inversely correlated with gait speed (r = −.14; p < .001) 
and stride length (r = −.18; p < .001). As lower values in LogMAR 
correspond to better VA, this indicates that better VA is corre-
lated with better gait performance (see Table 2 and Supplementary 
Figure A1.1). At all spatial frequencies, CS was correlated with 
gait speed (r = .08 to .16, p < .001) and stride length (r = .12 to 
.22, p < .001). VA and CS were not correlated significantly with 
cadence.
Multivariate Analysis of Vision and Gait
Visual acuity
There was no evidence of an association between VA and any gait 
variable in either model 1 or model 2 (see Table 3 and Supplementary 
Tables A1.1–A1.3).
Contrast sensitivity
Figure 1A shows the regression coefficients from the models exam-
ining associations between CS at each of these five individual spa-
tial frequencies and gait speed. Higher CS at low spatial frequencies 
was associated with faster gait speed in model 1 (CS at 1.5 cpd, 
β = .053; p < .001; CS at 3 cpd, β = .033; p < .001). After adjustment 
(and correction for multiple testing), there was no evidence of an 
association remaining in model 2 (Table 3).
Figure 1B indicates that poorer CS was associated with shorter 
stride length at lower spatial frequencies in model 1 (1.5 cpd 
[β = .051; p = .001]; 3 cpd [β = .036; p < .001]) with evidence of 
a trend at mid frequencies (6 cpd [β = .024; p = .002]). In model 2, 
CS at 1.5 cpd (β = .031; p = .001) and 3 cpd (β = .029; p = .001) 
remained significant after correcting for multiple testing (Table 3).
There was no clear evidence of an association between CS and 
cadence in either model 1 or model 2 (see Figure 1C and Table 3).
Discussion
Results from this study suggest that reductions in CS but not VA are 
independently associated with poorer gait performance.
Our findings support previous studies reporting that better CS is 
associated with increased stride length (10,11,15). However, ours is 
Table 1. Characteristics of the Participants (n = 4,678)
Characteristics Mean (SD) or Median (IQR) or % (N)
Age (y) 61.7 SD (8.3)
Sex (% woman) 54.1 (2,529)
Primary or no formal education 
(%)
21.3 (994)
Weight (kg) 79.2 SD (16.2)
Height (cm) 166.3 SD (9.1)
Medical history
 Chronic conditions ≥2 (%) 45.3 (2,119)
 Falls (%)—one or more 19.7 (920)
 Glaucoma (%) 1.93 (90)
 AMD (%) 1.48 (69)
 Cataracts (%) 8.3 (386)
 Anti-depressants 5.7 (265)
 Alpha blockers 1.4 (66)
 Beta blockers 12.1 (566)
 Calcium channel blockers 8.3 (389)
 Diuretics 6 (281)
 ACE/ARB 22 (1,029)
 Psychotropics 5.3 (246)
Cognitive and mental health
 MMSE (range 1–30) 28.7 SD (1.6)
 CES-D 4.4 SD (4.0)
 CRT (ms) 806 SD (260.7)
 Color trail time (s) 53.7 SD (26.7)
 Grip strength (kg) 27.5 SD (9.8)
Gait function
 Gait speed (cm/s) 136.1 SD (20.4)
 Cadence (steps/min) 115.6 SD (10.4)
 Stride Length (cm) 141.6 SD (17.6)
Visual function
 Corrective lenses 37.9 (1,772)
 Visual acuity (logMAR) 0.1 SD (0.2)
 CS 1.5 cpd 36.0 IQR (11)
 CS 3 cpd 57 IQR (23)
 CS 6 cpd 33.0 IQR (29)
 CS 12 cpd 0 IQR (15)
 CS 18 cpd 0 IQR (0)
Note: ACE/ARB  =  angiotensin converting enzyme/angiotensin receptor 
blockers; AMD  =  age-related macular degeneration; CES-D  =  Centre for 
Epidemiological Studies Depression scale; CRT = Choice reaction time (total 
time); CS = contrast sensitivity; cpd = cycles per degree; MMSE = Mini-Mental 
State Exam; IQR = interquartile range. Corrective Lenses = Wore corrective 
lenses as required.
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the first study to measure CS at multiple spatial frequencies across 
the low, mid, and high range. This is a more appropriate method of 
characterizing CS and allows us to gain further insight into this rela-
tionship. Results suggest that the relationship between CS and gait 
is spatial frequency dependent, with poorer CS at lower spatial fre-
quencies associated with shorter stride length. Our regression results 
would suggest that these results have a small effect size which trans-
lates into a 2.65 cm difference in stride length between the 5th and 
95th percentiles of CS. Although a small effect size, when combined 
with other falls risk factors, this magnitude of difference could affect 
an individual’s ability to avoid tripping over an obstacle.
The association between CS (at lower spatial frequencies) and 
stride length is intuitively satisfying and provides a possible mecha-
nistic link between vision, gait, and future falls. Previous research 
has shown that low-to-mid spatial frequencies play a role in object 
detection (24,25), and those with poorer CS may shorten their 
stride length to accommodate for being unsure of their surround-
ings. Shorter stride lengths coupled with a higher cadence have 
been observed in older fallers (26) while shortened stride length and 
reduced speed is associated with increased falls risk in older adults 
(27) and hospitalized patients (28). Thus by contributing to gait 
impairments and impaired object detection, poor CS may contribute 
to object avoidance (29) and increased falls risk. In considering the 
clinical application of these results as a screening tool it may be more 
convenient to test for low spatial frequency only, that is, using only 
the low-frequency components of the F.A.C.T. (20).
Finally, our results examining VA supports previous research 
reporting significant univariate (but no multivariate) correlations 
between VA and gait variables (9,11,12). Owsley and colleagues (25) 
note that VA did not contribute to the detection of real world objects 
while Hassan and colleagues (30) reported no evidence of an asso-
ciation between VA and mobility over a complicated obstacle course. 
Our results after adjustment suggest that high contrast, detailed 
vision (as measured by VA) may not be essential to basic straight 
line walking. This is in agreement with previous studies that have 
indicated that CS is a better measure for fall risk than VA (6,31,32). 
Despite this, assessment of VA is included in the falls screening and 
assessment guidelines (8). The evidence provided here suggests that 
the inclusion of VA alone requires re-evaluation as a more compre-
hensive visual assessment may be more appropriate.
Results of additional sensitivity analyses would suggest that 
the regression estimates are robust after adjusting for age2 and 
Table 2. Univariate Correlations Between Visual Function (VA and CS) and Gait (Gait Speed, Cadence and Stride Length).
VA CS 1.5 cpd CS 3 cpd CS 6 cpd CS 12 cpd CS 18 cpd
Gait speed −0.14*** 0.12*** 0.16*** 0.13*** 0.13*** 0.08***
Cadence 0.01 −0.02 −0.03* −0.02 −0.02 −0.03
Stride length −0.18*** 0.16*** 0.22*** 0.18*** 0.17*** 0.12***
Note: cpd = cycles per degree; CS = contrast sensitivity; VA = Visual acuity.
*p ≤ .05; **p ≤ .01; ***p ≤ .001.
Table 3. Multivariate Model Estimates of the Association Between VA, CS, and Gait Function (Gait Speed, Cadence, Stride Length)
Gait Speed (cm/s) Cadence (footfalls per min) Stride Length (cm)
β (95% CI) β (95% CI) β (95% CI)
VA
 Model 1 −1.53 (−4.71, 1.65) 0.29 (−1.17, 1.76) −2.14 (−4.50, 0.22)
 Model 2 −1.32 (−4.45, 1.82) −0.025 (−1.55, 1.50) −1.43 (−3.72, 0.87)
CS A (1.5 cpd)
 Model 1 0.053 (0.025, 0.08)*** 0.0053 (−0.0083, 0.019) 0.051(0.031,0.071)***
 Model 2 0.029 (0.0029, 0.056)* −0.00018 (−0.013, 0.014) 0.031 (0.013, 0.049)***
CS B (3 cpd)
 Model 1 0.033 (0.017,0.049)*** −0.00016 (−0.0083,0.008) 0.036 (0.024,0.048)***
 Model 2 0.015 (−0.001, 0.031) −0.003 (−0.012, 0.004) 0.021 (0.009, 0.032)***
CS C (6 cpd)
 Model 1 0.011 (−0.0087, 0.031) −0.0082 (−0.018, 0.0016) 0.024 (0.009,0.038)**
 Model 2 −0.0058 (−0.025, 0.014) −0.011 (−0.021, −0.001)* 0.008 (−0.005, 0.022)
CS D (12 cpd)
 Model 1 0.0075 (−0.046, 0.061) −0.023 (−0.047, 0.00035) 0.039 (0.0007, 0.077)*
 Model 2 −0.014 (−0.064, 0.037) −0.024 (−0.048, −0.00068)* 0.016 (−0.018, 0.051)
CS E (18 cpd)
 Model 1 0.047 (−0.14, 0.24) −0.061 (−0.15, 0.025) 0.12 (−0.017, 0.26)
 Model 2 −0.024 (−0.209, 0.16) −0.07 (−0.15, 0.014) 0.056 (−0.077, 0.19)
Note: A–E = visual targets of increasing spatial frequency and varying CS; CI = confidence interval; cpd = cycles per degree; CS = contrast sensitivity; MMSE = Mi-
ni-Mental State Exam; VA = visual acuity. Model 1 = multivariate model adjusted for age, gender, education, height and weight; Model 2 = multivariate model 
adjusted for age, gender, education, height, weight, history of falls, medications including: α-, β- & calcium channel blockers, diuretics, angiotensin-converting-
enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), antidepressants and psychotropics, self-reported unsteadiness, corrective lens wearing, number of 
chronic diseases, depressive symptoms, color trail time, MMSE, total response time from the Choice Reaction Time (CRT) test, grip strength, history of cataracts, 
treated and untreated, history of glaucoma and age-related macular degeneration (AMD).
*p ≤ .05; **p ≤ .01; ***p ≤ .001.
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age–sex interactions which are known to influence gait. Furthermore, 
although we applied a false discovery rate approach to correct for 
multiple testing effects, we also tested the effect of using the aver-
age CS value for each participant in a sensitivity analysis, which 
has methodological advantages of increasing the precision of our 
estimates, normalizing the model residuals, and minimizing multiple 
testing effects. Again our results were consistent with CS associated 
with stride length.
This study has a number of strengths including the measurement 
of CS at individual spatial frequencies. Secondly it utilizes a large rep-
resentative sample, coupled with a comprehensive health, socioeco-
nomic profile of each participant enabling statistical inferences to be 
made which are more generalizable to the broader older community 
dwelling adult population. There are, however, a number of limita-
tions to the study. It is cross-sectional limiting any conclusions regard-
ing causation. Analysis was limited to those who attended a health 
center assessment. This cohort is relatively young (mean age 62 years), 
healthy (gait speed and VA mostly within healthy ranges) and therefore 
is less representative of frailer adults. The gait assessment task used in 
this study reflects straight line walking undertaken in conditions of 
high luminance, contrast and is free from hazards. The role of vision 
in this context is likely less critical than under more challenging condi-
tions comprising obstacle avoidance and lower lighting which may 
account for small effect size detected here (12,32,33). In light of these 
results, a more comprehensive battery of visual tests should be consid-
ered including stereoacuity and visual field size (34). However, CS is 
most reflective of real world vision as it includes object of varying size 
and contrast unlike VA or stereoacuity. Although important fall risk 
covariates, lower limb strength and standing balance, were not meas-
ured directly, we controlled for grip strength which is known to corre-
late well with lower limb strength (35,36). During sensitivity analysis 
we adjusted for self-reported steadiness as a surrogate for standing 
balance. This did not alter associations between CS and gait.
Conclusion
Reduced CS, particularly at low spatial frequencies, is independently 
associated with shorter stride length, while VA is not associated 
with gait performance. VA is currently included in the American 
Geriatrics Society/ British Geriatrics Society guidelines for screening 
and assessment of falls in community dwelling adults. The evidence 
provided here would suggest that future studies should examine lon-
gitudinally, or in a randomized controlled manner, the associations 
between CS and other measures of visual function with gait espe-
cially in the context of falls. This may ultimately lead to a refocus 
of the clinical exam to include assessment of the most appropriate 
measures of visual function.
Supplementary Material
Supplementary data are available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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